Interview with Alina Culcea, Managing Director, Actavis Romania
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
Address: Actavis Romania, Ion Mihalache Blvd. 11, sector 1, Bucharest 011 171, Romania
Tel: +40 21 351 45 67
Web: http://www.actavis.com.ro/ro/default.htm
Having joined Actavis Group in March 2006, the Romanian division strengthens the group’s oncology actavities. The Romanian branch embraces the Group’s center of excellence for the development, production and marketing of generic oncology medicines.
With a broad portfolio of oncology products, the company has a successful presence in a growing number of foreign markets. The latest market within the portfolio are in the United States and Japan, where since 2008, the company sells oncology products manufactured in the production unit in Bucharest – Sindan Pharma, a company previously acquired by Actavis Group in 2006.
Actavis offers its customers the broadest product portfolio and the most advanced production line of generic drugs. Currently, Actavis sells over 830 products (over 10,000 SKUs) in hospitals and pharmacies around the world, covering all relevant therapeutic areas. In 2008, the Company has launched over 660 products (235 molecules) and for 2009 it is expected that number to rise to 800 launches of new products.
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
Sorin Petcu of IQVIA Romania explains how financing, a lack of medical professionals, and an array of unmet needs are the major trends currently shaping Romanian healthcare. Petcu highlights IQVIA’s…
Gabriel Cernica, general manager of Cegedim Customer Information and Cegedim Rx Romania, analyses the main trends shaping the pharmaceutical and healthcare environment in Romania and their effect on Cegedim’s business.…
Amalia Mihai, market access manager of Ipsen Romania explains that over the course of 26 years Ipsen has been increasingly helping Romanian patients in the field of oncology, neurodegenerative disorders,…
Daniel Bran, GM of Accord Romania reveals that finding the right talent has been one of the most challenging and rewarding milestones in building the affiliate from the ground up.…
Cătălin Vicol introduces Biofarm, a leading Romanian pharma producer on the verge of significant international expansion. Vicol shares his insights on the potential of the Romanian consumer healthcare (CHC) market,…
Jorge Levinson, head of Bayer Pharmaceuticals Romania and Moldova, reveals his first impressions of Romania and the untapped potential it offers to the company. He shares his insights on how…
Dana Constantinescu of GSK Romania reveals the importance of the affiliate to the regional group and how vaccines and HIV are driving its growth. She outlines how the affiliate’s portfolio…
Cătălin Radu of Bristol Myers Squibb (BMS) Romania explains how the Celgene acquisition is allowing the company to provide their expertise on a larger scale. He reveals how BMS has…
Cecilia Radu of Novo Nordisk Romania shares her tumultuous four years that have seen declining market share and have culminated in launching the company’s first new product onto the market…
Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the pharmaceutical industry in the country. He shares the…
Jorge Ruiz Benecke of AbbVie Romania outlines how the affiliate attained its leading position in the Romanian pharma market, the importance of agility in the decision-making process, and how he…
Fotis Kalantzis, general manager for the Romanian affiliate of OTC medicine and food supplement specialist Perrigo reveals how the switch to a consumer-centric model was inducive to winning an IQVIA…
See our Cookie Privacy Policy Here